CLINICAL ROLE -
Bacterial Enzyme Responsible for Crohn's Disease Development
Genetically engineering the gut microbiome may hold the key to treating Crohn’s disease.
Read More
Cancer Surgery Increases Risk of Opioid Addiction
Patients receiving adjuvant chemotherapy are at a high risk of new persistent opioid use.
Researchers Discover Eczema Subtypes
A newly-discovered eczema subtype may be linked to asthma and allergies.
Trending News Today: Financial Incentives May Increase Utilization of Preventive Services
Top news of the day from across the healthcare landscape.
Trending News Today: Colorado Lifts HCV Drug Limits for Medicaid Patients
Top news of the day from across the health care landscape.
FDA Approves Cancer Biomarker Test, CMS Suggests Insurance Coverage Options
Centers for Medicare & Medicaid Services proposed national coverage determination of the FoundationOne CDx test.
Blood-Brain Barrier May Present Treatment Target in Multiple Sclerosis
Targeting specific transportation system across the damaged blood-brain barrier could halt MS disease progression.
Taltz Gets FDA Approval for Psoriatic Arthritis
Ixekizumab found to provide significant improvement in joint symptoms for patients not previously treated with a biologic disease-modifying antirheumatic drug.
Medication Management in Schools: Pharmacist Involvement Can Improve Outcomes
Between 10% and 20% of students in kindergarten through high school have chronic illness.
FDA OKs Evolocumab for Prevention of Cardiovascular Events
The FDA extended the approval of evolocumab (Repatha, Amgen) to include the prophylaxis of heart attacks, strokes, and coronary revascularizations in adults with established heart disease.
Evolocumab Approved to Prevent Heart Attack, Stroke
Evolocumab (Repatha) is the only PCSK9 inhibitor approved to prevent heart attack, stroke, and coronary revascularization.
FDA Notes Progress Implementing 21st Century Cures Act
FDA plans to further expedite novel treatments under the 21st Century Cures Act.
Confirmatory HIV Testing May Reduce Misdiagnosis Among Pediatric Patients
A second HIV test may avoid significant costs.
Investigational ALS Drug Fails in Phase 3 Clinical Trial
Development of tirasemtiv halted due to poor performance in a late-stage clinical trial.
Global Diabetes Rates Continue to Climb
Nearly 700 million individuals around the world will develop diabetes by 2045, many of whom are undiagnosed.
Diabetes Linked to Breast Cancer Risk in African American Women
Women with type 2 diabetes were 43% more likely to develop estrogen receptor negative breast cancer than patients without diabetes.
Trending News Today: CVS-Aetna Merger Could Change Healthcare
Trending News Today: FDA Approves Cancer-Gene Profiling Test
New CDC Guidelines Target Hepatitis B
Screening for HBV among high-risk populations is crucial to stopping transmission of the virus.
Cosentyx Shows Promise Treating Nail, Palmoplantar Psoriasis
Patients with moderate-to-severe nail psoriasis treated with secukinumab experienced significant improvement in the Nail Psoriasis Severity Index.
Trelegy Ellipta for COPD: What Pharmacists Should Know
The medication is indicated for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease.
We Are All Clinical Pharmacists
Drop the modifier, as it is causing a rift in the profession.
When All is Said and Done, Do Pharmacists Like Immunizing?
As professions expand their scopes of practice, it is critical to step back periodically and examine how the change has affected the profession and the individuals within the profession.
Opioid Use Disorder Drug Approval Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
FDA OKs Biosimilar Treatment for Certain Breast and Stomach Cancers
The FDA has approved trastuzumab-dkst (Ogivri, Mylan GmbH) as a biosimilar to trastuzumab (Herceptin, Genentech), the first biosimilar for the treatment of certain breast and stomach cancers.
Connecting the Dots for a Digital Deploy: A Guide to Engaging Pharma Stakeholders
Strategic tips for pharma to develop an overall business strategy around digital engagement.
First Biosimilar Approved for Breast, Stomach Cancers
Trastuzumab-dkst (Ogivri) is the second biosimilar approved for cancer.
Marriage, Partnership Impacts Adherence to Cancer Treatment Guidelines
Patients with a partner were nearly twice as likely to finish 6 months of chemotherapy for colon cancer.
Twenty-One Million HIV Patients Now Have Access to Antiretroviral Therapy
Nearly 21 million individuals with HIV had access to antiretroviral therapy (ART) in June 2017 compared to 685,000 HIV-positive patients in 2000.
Medicare Updates Value-Based Design for 2019
Twenty-five states can participate in value-based insurance designs for Medicare Advantage plans in 2019.
